Back | Next |
home / stock / vxrt / vxrt message board
Subject | By | Source | When |
---|---|---|---|
Vaxart Publishes Clinical Data Suggesting its Oral COVID-19 | Tamtam | investorshub | 07/20/2022 11:51:22 PM |
$VXRT Vaxart Inc | mick | investorshub | 07/18/2022 12:07:42 AM |
whytestocks: $VXRT News Article - Vaxart Provides an Update on Proxy Voting and Urges All Stockholde | whytestocks | investorshangout | 07/01/2022 2:30:53 PM |
Vaxart is doing worse than I expected | Tamtam | investorshub | 06/30/2022 11:37:57 PM |
whytestocks: $VXRT News Article - Vaxart Announces Agreement with hVIVO to Develop World's First Hum | whytestocks | investorshangout | 06/30/2022 4:55:51 PM |
Vaxart Inc ($VXRT) | mick | investorshub | 06/06/2022 4:58:46 AM |
Nice day | Tamtam | investorshub | 05/28/2022 10:58:21 AM |
No to all questions. | conix | investorshub | 05/06/2022 6:33:33 PM |
Hey Conix, are you on Stocktwits by any | YJ4LIFE | investorshub | 05/06/2022 3:13:42 PM |
$VXRT Vaxart Inc | mick | investorshub | 05/02/2022 2:24:20 PM |
I know :-) | Tamtam | investorshub | 05/02/2022 6:03:22 AM |
https://www.otcmarkets.com/stock/$VXRT | mick | investorshub | 05/01/2022 11:45:49 PM |
$VAXART ah favorite | mick | investorshub | 05/01/2022 11:45:09 PM |
Thanks Mick | Tamtam | investorshub | 05/01/2022 9:14:04 PM |
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar | mick | investorshub | 05/01/2022 7:34:52 PM |
Vaxart Inc ($VXRT) | mick | investorshub | 05/01/2022 7:34:29 PM |
Vaxart Inc ($VXRT) | Tamtam | investorshub | 04/03/2022 10:15:14 AM |
Vaxart Inc ($VXRT) | mick | investorshub | 03/12/2022 8:12:51 PM |
whytestocks: $VXRT News Article - These 19 Words From Vaxart Could Mean Trouble for Vaccine Rivals | whytestocks | investorshangout | 03/09/2022 8:40:52 PM |
Vaxart Inc ($VXRT) | Tamtam | investorshub | 02/25/2022 7:42:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Palo Alto Networks, Inc. (NASDAQ:PANW) reported its third-quarter financial results after the bell Monday. Here's a look at the details from t...
Vaxart, Inc. (NASDAQ:VXRT) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details...
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine a...